Please wait a minute...

中国生物工程杂志

China Biotechnology
China Biotechnology  2019, Vol. 39 Issue (9): 33-40    DOI: 10.13523/j.cb.20190905
Orginal Article     
Methodological Study on Flow Detection of PNH Clone and Its Clinical Screening Significance
YUAN Xiao-ying,WANG Ya-zhe,SHI Wei-hua,CHANG Yan,HAO Le,HE Ling-ling,SHI Hong-xia,HUANG Xiao-jun,LIU Yan-rong()
Peking University Peoples’Hospital, Peking University Institute of Hematology,National Clinical Research Center for Hematologic Disease, Beijing 100044, China
Download: HTML   PDF(2289KB) HTML
Export: BibTeX | EndNote (RIS)      

Abstract  

Objective: To explore the importance and clinical indications of high-sensitivity assay detecting PNH clones by flow cytometry and the incidence and clinical significance of PNH clones in patients with hematopenia.Methods: FLAER combined with CD24 or CD14 was used to detect the percentage of PNH clones in granulocytes and monocytes, and CD59 was used to detect the percentage of PNH clones in erythrocytes of 20 healthy volunteers and 1 095 patients with hematopenia. Meanwhile, CD59 negative percentage in granulocytes and monocytes of 31 patients was detected by traditional CD59 method.Results: According to background of volunteers and numbers of cells, limited of detection (LOD) of granulocytes, monocytes and erythrocytes were 0.04%, 0.10% and 0.05%, respectively. The median percentages of FLAER -CD24 - granulocytes, FLAER -CD14 - monocytes and CD59 - erythrocytes were 0.02%, 0.02% and 0.03% in 827 patients, separately. The proportions of PNH clones in granulocytes were above LOD in 318 patients. Among of 180 patients with PNH clones below 1.00%, the consistent rates of granulocytes with monocytes and erythrocytes were from 43% to 45%. When the percentages of PNH clones in granulocytes were more than 1.00%, the consistency rates of granulocytes with monocytes and erythrocytes were around 90.00%. Comparing the percentage of CD59 negative granulocytes and monocytes with that of FLAER and anchor protein double negative, the former was significantly lower than the latter (P< 0.000 1 and P=0.000 9). The percentages of FLAER single negative granulocytes were higher than that of FLAER and anchor protein double negative cells in 26.85% patients. The similar results occured in monocytes of 24.54% patients. The patients with PNH clones below 0.10% were affected more easily. PNH clones were 90.30% (44.49%~99.05%) in 36 patients with PNH and 1.30% (0.10%~96.07%) in 50 patients with MDS or AA, separately (P<0.000 1). When PNH clone was 41.81%, the sensitivity and specificity of PNH diagnosis were 100.0% and 96.0%, respectively. Conclusion: In this study, the LOD of granulocyte and erythrocyte was 0.04% and 0.05% respectively. When the proportion of PNH clones in granulocytes is more than 1.00%, the positive results of monocytes and erythocytes are more consistent. PNH disease is more likely when the proportion of PNH clones is higher than 41.81%.



Key wordsPNH clone      FLAER      Flow cytometry     
Received: 04 September 2019      Published: 20 September 2019
ZTFLH:  Q291  
Corresponding Authors: Yan-rong LIU     E-mail: yrliu163@163.com
Cite this article:

YUAN Xiao-ying,WANG Ya-zhe,SHI Wei-hua,CHANG Yan,HAO Le,HE Ling-ling,SHI Hong-xia,HUANG Xiao-jun,LIU Yan-rong. Methodological Study on Flow Detection of PNH Clone and Its Clinical Screening Significance. China Biotechnology, 2019, 39(9): 33-40.

URL:

https://manu60.magtech.com.cn/biotech/10.13523/j.cb.20190905     OR     https://manu60.magtech.com.cn/biotech/Y2019/V39/I9/33

Fig.1 Gating strategy of PNH clones in erythrocytes, granulocytes and monocytes
粒细胞
PNH克隆比例
n 单-红- 单+红+ 单-红+ 单+红- 粒单一致
(n/%)
粒红一致
(n/%)
粒单红一致
(n/%)
<0.04% 509 348 11 123 27 471(92.53) 375(73.67) 348(68.37)
0.04%~0.20% 101 50 15 17 19 34(33.66) 32(31.68) 15(14.85)
0.20%~0.99% 79 21 34 12 12 46(58.23) 46(58.23) 34(43.04)
1.00%~9.99% 53 1 41 2 9 50(94.34) 43(81.13) 41(77.36)
10.00%~49.99% 28 0 26 0 2 28(100.0) 26(92.86) 26(92.86)
50.00%~100.0% 57 0 57 0 0 57(100.0) 57(100.0) 57(100.0)
Table 1 Distribution of PNH clones in granulocytes、monocytes and erythrocytes(N=827)
Fig.2 Correlation of PNH clones in granulocytes and monocytes detected by FLAER combined with anchor protein and CD59
Fig.3 Comparison of PNH clones in granulocytes and monocytes detected by FLAER and anchor protein double negative and CD59 single negative.
Fig.4 ROC curve of PNH clones in PNH and MDS/AA patients
[1]   Parker C J . Historical aspects of paroxysmal nocturnal haemoglobinuria: ‘Defining the disease’. Br J Haematol, 2002,117(1):3-22.
[2]   Parker C J . Bone marrow failure syndromes: Paroxysmal nocturnal hemoglobinuria. Hematol Oncol Clin North Am, 2009,23(2):333-346.
[3]   Parker C, Omine M, Richards S , et al. Diagnosis and management of paroxysmal nocturnal hemoglobinuria. Blood, 2005,106(12):3699-3709.
[4]   Borowitz M J, Craig F E, DiGiuseppe J A, et al. Guidelines for the diagnosis and monitoring of paroxysmal nocturnal hemoglobinuria and related disorders by flow cytometry. Cytometry B Clin Cytom, 2010,78(4):211-230.
[5]   中华医学会血液学分会. 骨髓增生异常综合征诊断与治疗专家共识. 中华血液学杂志, 2012,33(4):347-352.
[5]   Chinese Society of Hematology . The diagnosis and treatment of myelodysplastic syndrome. Chinese Journal of Hematology, 2012,33(4):347-352.
[6]   Marsh J C, Ball S E, Cavenagh J , et al. Guidelines for the diagnosis and management of aplastic anaemia. Br J Haematol, 2009,147(1):43-70.
[7]   Hernández-Campo P M, Almeida J, Sánchez M L , et al. Normal patterns of expression of glycosylphosphatidylinositol-anchored proteins on different subsets of peripheral blood cells: a frame of reference for the diagnosis of paroxysmal nocturnal hemoglobinuria. Cytometry B Clin Cytom, 2006,70(2):71-81.
[8]   Brodsky R A, Mukhina G L, Li S , et al. Improved detection and characterization of paroxysmal nocturnal hemoglobinuria using fluorescent aerolysin. Am J Clin Pathol, 2000,114(3):459-466.
[9]   Hernández-Campo P M, Almeida J, Matarraz S , et al. Quantitative analysis of the expression of glycosylphosphatidylinositol-anchored proteins during the maturation of different hematopoietic cell compartments of normal bone marrow. Cytometry B Clin Cytom, 2007 , 72(1):34-42.
[10]   Richards S J, Whitby L, Cullen M J , et al. Development and evaluation of a stabilized whole-blood preparation as a process control material for screening of paroxysmal nocturnal hemoglobinuria by flow cytometry. Cytometry B Clin Cytom, 2009,76(1):47-55.
[11]   杨柯, 郭晓宇, 欧剑锋 , 等. 外周血粒细胞CD55, CD59和FLAER检测在贫血及PNH诊断中的意义. 现代检验医学杂志, 2017,32(3):6-10.
[11]   Yang K, Guo X Y, OU J F , et al. Diagnostic significance of detecting peripheral blood granulocyte CD55/CD59 and FLAER in anemia and PNH. Journal of Modern Laboratory Medicine, 2017,32(3):6-10.
[12]   梁悦怡, 谢守军 . FLAER多参数检测PNH克隆的意义. 国际检验医学杂志, 2016,37(8):1139-1141.
[12]   Liang Y Y, Xie S J . FLAER multiparameter detection PNH cloning significance. International Journal of Laboratory Medicine, 2016,37(8):1139-1141.
[13]   Olteanu H, Karandikar N J, McKenna R W, et al.Differential usefulness of various markers in the flow cytometric detection of paroxysmal nocturnal hemoglobinuria in blood and bone marrow. Am J Clin Pathol, 2006,126(5):781-788.
[1] HE Ling-ling,LUO Ting-ting,CHANG Yan,WANG Ya-zhe,YUAN Xiao-ying,SHI Wei-hua,LAI Yue-yun,SHI Hong-xia,QIN Ya-zhen,HUANG Xiao-jun,LIU Yan-rong. Analysis on the Laboratory Examination Characteristics in 28 Patients with Acute Megakaryoblastic Leukemia[J]. China Biotechnology, 2019, 39(9): 2-10.
[2] ZHAO Si-shu,LIU Lu,LIU Fang,QIU Hai-rong,FAN Lei,LI Jian-yong,WU Yu-jie. Diagnostic Value of CD11c Antigen in Patients with Chronic Lymphocytic Leukemia[J]. China Biotechnology, 2019, 39(9): 19-24.
[3] HUI Yi-hua,WANG Hai-na,QI Yu-feng,CAO Xue-ling,GUAN Xue-mei,DUAN Jing-jing,DUAN Yi- jun,WANG Yan- feng,SU Wen. Normal Reference Range of Lymphocyte Subsets in Healthy Adults in Shanxi Province[J]. China Biotechnology, 2019, 39(9): 41-49.
[4] Hang Hai-ying,Liu Chun-chun,Ren Dan-dan. Development, Application and Prospection of Flow Cytometry[J]. China Biotechnology, 2019, 39(9): 68-83.
[5] PENG Xian-gui,YANG Wu-chen,LI Jia,GOU Yang,WANG Ping,LIU Si-heng,ZHANG Yun,LI Yi,ZHANG Xi. The Application of Related Cytomorphological Technology in Hematological Neoplasms Research Progress[J]. China Biotechnology, 2019, 39(9): 84-90.
[6] WEI Jin-mei, FAN Xiao-qin, XIONG Hai-ting, GAO Xue-juan, LIU Xiao-hui, LIU Lang-xia. hnRNPK Interacts with Nef and Facilitates the Cell Surface Expression of CD4[J]. China Biotechnology, 2015, 35(4): 17-22.
[7] . Effects of Serum Deprivation,Confluence and Cycloheximide[J]. China Biotechnology, 2008, 28(12): 57-61.
[8] . Effect of flow cytometrically-sorted sperm on chromosomes of bovine blastocysts produced in vitro[J]. China Biotechnology, 2007, 27(1): 98-101.
[9] . The investigation of the effect on human Hepatoma Cell apoptosis induced by Resibufogenin[J]. China Biotechnology, 2006, 26(06): 36-39.